Cataract Repair: 20-Year Outcomes In Diabetic Patients

Cataract Repair: 20-Year Outcomes In Diabetic Patients Overview This study aimed to assess the 20-year outcomes in terms of best-corrected visual acuity (BCVA) and subjective visual function, as measured by the VF-14 questionnaire, following cataract surgery in individuals with type 2 diabetes compared to those without diabetes. A prospective, longitudinal, population-based cohort study

Cefuroxime Prophylaxis For Cataract Postoperative Endophthalmitis

Cefuroxime Prophylaxis For Cataract Postoperative Endophthalmitis In their meta-analysis, the researchers aimed to evaluate the impact of prophylactic intracameral cefuroxime injection on postoperative endophthalmitis in cataract surgery. They conducted a comprehensive review of the literature up to July 2022, which included a total of 1,167,197 participants who underwent cataract surgery. Out

iStent Combination Therapy for Glaucoma and Cataracts

iStent Combination Therapy for Glaucoma and Cataracts Considering that glaucoma is the most common cause of irreversible vision loss and the third most common cause of vision loss worldwide, with cataracts and refractive error being the most prevalent causes, iStent combination therapy to treat glaucoma and cataracts has high therapeutic value. 

Cataract Repair: 20-Year Outcomes In Diabetic Patients